Patent details

EP3167902 Title: ANTIBODY BINDING ALPHA4BETA7 INTEGRIN AND ITS USE TO TREAT INFLAMMATORY BOWEL DISEASE

Basic Information

Publication number:
EP3167902
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP161915582
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTIBODY BINDING ALPHA4BETA7 INTEGRIN AND ITS USE TO TREAT INFLAMMATORY BOWEL DISEASE
French Title of Invention:
ANTICORPS A LIAISON D'INTEGRINE ALPHA4BETA7 ET SON UTILISATION POUR TRAITER LES MALADIES INTESTINALES INFLAMMATOIRES
German Title of Invention:
ALPHA4BETA7-INTEGRIN-BINDENDER ANTIKÖRPER UND DESSEN VERWENDUNG ZUR BEHANDLUNG ENTZÜNDLICHER DARMERKRANKUNGEN
SPC Number:

Dates

Filing date:
13/04/2001
Grant date:
29/07/2020
EP Publication Date:
17/05/2017
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/07/2020
EP B1 Publication Date:
29/07/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
13/04/2021
Renunciation date:
Revocation date:
30/12/2020
Annulment date:

Owner

From:
22/07/2020
 
 

Name:
GENENTECH, INC.
Address:
1 DNA Way, South San Francisco, CA 94080-4990, United States (US)

Name:
Millennium Pharmaceuticals, Inc.
Address:
40 Landsdowne Street, Cambridge, MA 02139, United States (US)

Inventor

1

Name:
ALLISON, David Edward
Address:
United States (US)

2

Name:
BRETTMAN, Lee R
Address:
United States (US)

3

Name:
FOX, Judith A.
Address:
United States (US)

Priority

1

Priority Number:
550082
Priority Date:
14/04/2000
Priority Country:
United States (US)

2

Priority Number:
748960
Priority Date:
27/12/2000
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/52; A61K 31/57; A61K 31/60; A61K 31/635; A61K 39/395; A61P 37/06;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2021/01
Publication date:
05/01/2021
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

1

Issue number:
202031
Publication date:
29/07/2020
Description:
Grant (B1)

2

Issue number:
202053
Publication date:
30/12/2020
Description:
Decision on revocation request
Filing date Document type Number of pages